Mutation analysis of peroxisome proliferator-activated receptor-γ coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Aim/hypothesis This study aimed to investigate if variability in the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with Type II (non-insulin-dependent) diabetes mellitus.Methods The PGC-1 gene was examined in 53 Type II diabetic patients applying single strand conformational polymorphism analysis followed by nucleotide sequencing. Identified variants were genotyped in an association study comprising 483 Type II diabetic patients and 216 glucose-tolerant control subjects. A replication study was done in an additional 201 Type II diabetic patients and 293 glucose-tolerant subjects. Furthermore, a potential interaction between the Pro12Ala polymorphism of PPAR-gamma2 and the PGC-1 Gly482Ser variant on risk of Type II diabetes was investigated.Results A total of seven variants (Ser74Leu, IVS2 + 52C-->A, Thr394Thr, Asp475Asp, Gly482Ser, Thr528Thr, and Thr612Met) were identified and investigated in an association study. Six of the variants showed no association with Type II diabetes in the initial study. However, the Gly482Ser polymorphism, was more frequent among Type II diabetic patients (37.0 %) than among glucose-tolerant subjects (30.8 %) (p = 0.032). In a replication study the difference in allele frequencies of the Gly482Ser variant remained significant (p = 0.0135). The combined study yielded an allele frequency of 37.3 % (34.7-39.9) for Type II diabetic patients and 30.5 % (27.7-33.4) for glucose-tolerant subjects (p = 0.0007). No interaction between this variant and the Pro12Ala polymorphism of PPAR-gamma2 was observed.Conclusion/interpretation A widespread Gly482Ser polymorphism of PGC-1 is associated with a 1.34 genotype relative risk of Type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transcriptional analysis reveals that expression of PGC-1α target genes is coordinately down-regulated in human diabetics [84, 85] and PGC-1α genetic polymorphisms have been linked to Type II Diabetes [104, 105].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E. H., et al. (2000) · Nature Genetics · doi:10.1038/79876 · Cited by 1,468
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Michael, L. F., Wu, Z., Cheatham, R. B., Puigserver, P., Adelmant, G., Lehman, J. J., Kelly, D. P., & Spiegelman, B. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061035098 · Cited by 663
The Pro12Ala Polymorphism in PPAR γ2 May Confer Resistance to Type 2 Diabetes
Hara, K., Okada, T., Tobe, K., Yasuda, K., Mori, Y., Kadowaki, H., Hagura, R., Akanuma, Y., Kimura, S., Ito, C., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2605 · Cited by 273
Hani, E. H., Boutin, P., Durand, E., Inoue, H., Permutt, M. A., Velho, G., & Froguel, P. (1998) · Diabetologia · doi:10.1007/s001250051098 · Cited by 264
Mori, H., Ikegami, H., Kawaguchi, Y., Seino, S., Yokoi, N., Takeda, J., Inoue, I., Seino, Y., Yasuda, K., Hanafusa, T., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.4.891 · Cited by 238
Cited by
Items 201–293 of 293
Sharma, R., Matharoo, K., Kapoor, R., & Bhanwer, A. J. S. (2017) · Molecular Genetics and Genomics · doi:10.1007/s00438-017-1385-2 · Cited by 17
Association between the PPARGC1A Polymorphism and Aerobic Capacity in Japanese Middle-aged Men
Nishida, Y., Iyadomi, M., Higaki, Y., Tanaka, H., Kondo, Y., Otsubo, H., Horita, M., Hara, M., & Tanaka, K. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3170 · Cited by 18
Zhang, Z., He, J., Qin, Y., Hu, Y.-Q., Miao, L. I., Liu, Y., Zhang, H., & Hu, W. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00489.x · Cited by 16
Huang, M. N., Claussnitzer, M., Saadat, A., Coral, D., Kalamajski, S., & Franks, P. W. (2023) · Diabetologia · doi:10.1007/s00125-023-05915-6 · Cited by 14
The Role of the PGC1α Gly482Ser Polymorphism in Weight Gain due to Intensive Diabetes Therapy
Deeb, S. S., & Brunzell, J. D. (2009) · PPAR Research · doi:10.1155/2009/649286 · Cited by 17
Jemaa, Z., Kallel, A., Sleimi, C., Mahjoubi, I., Feki, M., Ftouhi, B., Slimane, H., Jemaa, R., & Kaabachi, N. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.10.011 · Cited by 14
Prior, S. L., Clark, A. R., Jones, D. A., Bain, S. C., Hurel, S. J., Humphries, S. E., & Stephens, J. W. (2012) · Disease Markers · doi:10.1155/2012/416138 · Cited by 14
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics
Cresci, S. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2577 · Cited by 13
“There is considerable data on the association of PPARA, PPARD and PPARG polymorphisms with cardiovascular risk factors, particularly the incidence of Type 2 diabetes mellitus, obesity, insulin resistance and abnormal lipid profiles in European, American and Asian populations [7,92-102].”
BackgroundShapira, S., Kazanov, D., Dankner, R. S., Fishman, S., Stern, N., & Arber, N. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11010050 · Cited by 12
Jin, H., Hwang, I.-W., Kim, K., Cho, H. I., Park, T.-H., Shin, Y., Lee, H.-S., Hwang, J., Kim, A.-R., Lee, K.-H., et al. (2015) · Genes & Genomics · doi:10.1007/s13258-015-0380-4 · Cited by 15
“Moreover, the PPARGC1A 482Ser allele was associated with type 2 diabetes (Ek et al. 2001; Hara et al. 2002), and the individuals with 482 Gly allele had beneficial effects on the alteration of lipid oxidation and early insulin secretion (Muller et al. 2003; Eynon et al. 2010).”
BackgroundTobina, T., Mori, Y., Doi, Y., Nakayama, F., Kiyonaga, A., & Tanaka, H. (2016) · The Journal of Physiological Sciences · doi:10.1007/s12576-016-0491-y · Cited by 14
Bhatta, P., Bermano, G., Williams, H., & Knott, R. M. (2019) · Genomics · doi:10.1016/j.ygeno.2019.10.011 · Cited by 12
“[36] 134/1 59 61(1) 2001 Denmark (Non-A) 293 26.”
Ruchat, S.-M., John, W., Rankinen, T., Bouchard, C., Vohl, M., & Përusse, L. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.012 · Cited by 12
Balampanis, K., Chasapi, A., Kourea, E. P., Tanoglidi, A., Hatziagelaki, E. E., Lambadiari, V., Dimitriadis, G., Lambrou, G. Ι., Kalfarentzos, F., Melachrinou, M., et al. (2018) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2018.08.002 · Cited by 13
Correlation between PPARGC1A gene rs8192678 G>A polymorphism and susceptibility to type-2 diabetes
Du, F., Yang, K., & Piao, L. (2019) · Open Life Sciences · doi:10.1515/biol-2019-0006 · Cited by 11
Maver, A., Medica, I., Salobir, B., Terčelj-Zorman, M., Šabović, M., Petrovič, D., & Peterlin, B. (2008) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 12
Association of Polymorphisms in Mitofusin-2 Gene with Type 2 Diabetes in Han Chinese
Li, P., Zhu, S., Wu, X., Zhu, X., Li, J., Pan, L., Xin, Z., Niu, F., Wu, J., & Liu, Y. (2012) · BioMed Research International · doi:10.1155/2012/205752 · Cited by 11
The Molecular Basis of PPAR Function
Barak, Y., & Lee, C. (2010) · PPAR Research · doi:10.1155/2010/510530 · Cited by 15
Bailén, M., Tabone, M., Bressa, C., Montalvo-Lominchar, M. G., Larrosa, M., & González-Soltero, R. (2022) · Genes · doi:10.3390/genes13020289 · Cited by 11
“The Gly482Ser (T) allele has been ssociated with poor r m tochondrial function in skeletal muscle [20], with an increased ri k of T2DM [24], and the presence of the m or T allele seems to be overrepresented in studies focused on T2DM susceptibility [40].”
BackgroundInfluentialKaul, N., Singh, Y. P., & Bhanwer, A. J. S. (2015) · Gene · doi:10.1016/j.gene.2015.03.019 · Cited by 10
McCarthy, M. I. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543555.024 · Cited by 11
Iglseder, B., Oberkofler, H., Felder, T. K., Klein, K., Paulweber, B., Krempler, F., Trégouët, D., & Patsch, W. (2006) · Stroke · doi:10.1161/01.str.0000238584.57864.d4 · Cited by 10
Pharmacogenetics of the PPAR Genes and Cardiovascular Disease
Cresci, S. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.11.1581 · Cited by 9
Li, T., Wu, X., Zhu, X., Li, J., Pan, L., Li, P., Xin, Z.-H., & Liu, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0794-5 · Cited by 9
“HNF4A regulates and interacts with multiple transcription factors like peroxisome proliferator-activated receptorc [26], peroxisome proliferator-activated receptor coactivator-1a [27] and FOXO1 [28], all of which play a major role in the maintenance of glucose homeostasis and have been implicated in type 2 diabetes pa…”
BackgroundPark, S., Kim, B. C., & Kang, S. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.68 · Cited by 13
Large‐scale study of the −232C > G polymorphism of PCK1 in Type 2 diabetes
Wegner, L., Andersen, G., Albrechtsen, A., Sparsø, T., Glümer, C., Borch‐Johnsen, K., Jørgensen, T., Hansen, T. F., & Pedersen, O. B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01926.x · Cited by 9
Self-citationPathophysiology and Pathogenesis of Diabetic Nephropathy
Chen, S., Khoury, C. C., & Ziyadeh, F. N. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00078-1 · Cited by 13
Wallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 10
Xie, G., Guo, D., Li, Y., Liang, S., & Wu, Y. (2007) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-7-33 · Cited by 8
“Recently, several western population studies have studied the associations of Gly482Ser (G482S) and +2962A/G single nucleotide polymorphisms (SNP) of PGC-1α gene with blood pressure [6-10].”
BackgroundGenetic contributions to Type 2 diabetes: recent insights
Sale, M. M., & Rich, S. S. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.2.207 · Cited by 8
Genetics of Type 2 diabetes in Asian Indians
Radha, V., Kanthimathi, S., & Mohan, V. (2011) · Diabetes Management · doi:10.2217/dmt.11.14 · Cited by 7
Erkens, T., Rohrer, G. A., Zeveren, A. V., & Peelman, L. J. (2009) · Czech Journal of Animal Science · doi:10.17221/12/2009-cjas · Cited by 7
“Gly482Ser substitution and a few other SNPs in the coding region that have been associated with type II diabetes mellitus and body fat characteristics (Ek et al., 2001; Vimaleswaran et al., 2006).”
BackgroundInfluentialRuderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 9
Two new splice variants in porcine PPARGC1A
Erkens, T., Bílek, K., Zeveren, A. V., & Peelman, L. J. (2008) · BMC Research Notes · doi:10.1186/1756-0500-1-138 · Cited by 6
“Currently, human medicine shows a great interest in PPARGC1A, because of the important role this gene plays in the worldwide problems concerning obesity, insulin resistance and correlated diseases, such as type 2 diabetes mellitus [26,27].”
BackgroundAssociation study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes
Su, Y. R., Peng, S.-B., Li, Z.-Q., & Huang, Q.-Y. (2008) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2008.00304 · Cited by 6
Brettfeld, C., Englert, S., Aumueller, E., & Haslberger, A. G. (2012) · Italian Journal of Public Health · doi:10.2427/8694 · Cited by 6
Mitochondriogenesis Genes and Extreme Longevity
Santiago, C., Garatachea, N., Yvert, T. P., Rodríguez‐Romo, G., Santos‐Lozano, A., Fiuza‐Luces, C., & Lucía, A. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1382 · Cited by 5
Genetic Susceptibility to the Metabolic Syndrome
Lyssenko, V., & Groop, L. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50008-5 · Cited by 5
Wu, H., Liu, N., YANG, Z. K., Tao, X., Du, Y., Wang, X., Lü, B., Zhang, Z., Hu, R., & Wen, J. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-107 · Cited by 5
“Furthermore, PPARGC1A (rs8192678) has also been found to be associated with a higher risk of T2DM in Indian and East Asian populations [14,15].”
BackgroundErkens, T., SMET, S. D., den Maagdenberg, K. V., Stinckens, A., Buys, N., Zeveren, A. V., & Peelman, L. J. (2010) · Czech Journal of Animal Science · doi:10.17221/263/2009-cjas · Cited by 9
“…regulatory regions of PPARGC1A, have been independently associated with several fat characteristics in pigs, with milk fat yield in cattle and with obesity/type II diabetes in humans (Ek et al., 2001; Weikard et al., 2005; Jacobs et al., 2006; Vimaleswaran et al., 2006; Stachowiak et al., 2007).”
BackgroundMarín-García, J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404599-6.00012-3 · Cited by 7
Kim, J. S., Kim, J., Yee, J., Kim, S. J., Chung, J. E., & Gwak, H. S. (2023) · Pharmaceuticals · doi:10.3390/ph16071035 · Cited by 4
“In contrast, this SNP polymorphism did not demonstrate any significant association with T2DM in the Caucasian population [45].”
BackgroundPathophysiology and Pathogenesis of Diabetic Nephropathy
Wolf, G., Sharma, K., & Ziyadeh, F. N. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50081-4 · Cited by 5
Zambrano, M., Fernández, É., López, M., Rangel, A., de Romero, P., Fernández, V., Morales, L. M., Molero-Conejo, E., Connell, L., Raleigh, X., et al. (2009) · PubMed · Cited by 4
Rios, W. Q., Silva, C. M., Ferreira, R. M., & Gomes, J. R. B. (2026) · Journal of Molecular Medicine · doi:10.1007/s00109-026-02694-6 · Cited by 3
“The common missense polymorphism Gly482Ser (rs8192678) is linked to increased risk of T2DM across multiple populations, including Asian, African, and European cohorts [ 328–330].”
The Distribution of Sport Performance Gene Variations Through COVID-19 Disease Severity
Yenmiş, G., Kallenci, I., Dokur, M., Koç, S., Yalinkilic, S. B., Atak, E., Demirbilek, M., & Arkan, H. (2025) · Diagnostics · doi:10.3390/diagnostics15060701 · Cited by 3
“As a consequence, these individuals have an elevated risk of type 2 DM [40,41].”
[The role of molecular biology in the diagnosis and treatment of cardiovascular diseases].
Mariotti, S., Capparuccia, C., Ripa, C., Olivieri, F., Lisa, R., Procopio, A. D., & Antonicelli, R. (2010) · PubMed · Cited by 3
Elfihry, R., Elmessaoudi-Idrissi, M., Jadid, F., Zaidane, I., Chihab, H., Tahiri, M., Kabine, M., Badre, W., Chemin, I., Marchio, A., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00220-7 · Cited by 3
Schillemans, T., Tragante, V., Maitusong, B., Gigante, B., Cresci, S., Laguzzi, F., Vikström, M., Richards, M., Pilbrow, A. P., Cameron, V. A., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.909870 · Cited by 3
“In the Boston Puerto Rican Health Study, they found associations between polymorphisms in the PPARGC1A gene and DNA damage, T2D, and CVD (Lai et al., 2008b).”
BackgroundInfluentialThe Genetics of Type 2 Diabetes: From Candidate Gene Biology to Genome‐Wide Studies
Vaxillaire, M., & Froguel, P. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch12 · Cited by 9
Su, X., Dong, H. R., Yan, M. R., Cui, H., Yang, L. P., & Han, F. Q. (2011) · Genetics and Molecular Research · doi:10.4238/2011.december.12.2 · Cited by 3
“1%) (Ek et al., 2001; Lacquemant et al., 2002; Oberkofler et al., 2003) but lower than that in Chinese (42.”
BackgroundInfluentialPPAR/PGC-1 Regulation of Metabolism in Cardiac Disease
Duncan, J. G., & Finck, B. N. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-891-7_4 · Cited by 2
Thermogenesis and the Metabolic Syndrome
Bonet, M. L., Picó, C., & Palou, A. (2005) · Elsevier eBooks · doi:10.1016/b978-84-8174-892-5.50017-6 · Cited by 2
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_27-1 · Cited by 2
Bioenergetics and Type 2 Diabetes
Doliba, N. M. (2017) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000222 · Cited by 2
The role of PPARGC1A and the RS8192678 polymorphism in determining the performance of athletes
Melnyk, O. V., Sorokina, N. O., Lischishyn, H. V., Muzychuk, O. M., Botanevych, Y. O., Sukhan, D. S., & Liudkevych, H. P. (2022) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2022-26(3)-26 · Cited by 1
Li, H., Wang, Y., Zheng, W., Lü, J., Tang, C., Long, M., Liu, B., Chen, B., Li, W., & Xu, Z. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02721-4 · Cited by 2
“Under pathological conditions, the downregulated expression of PGC-1α in muscle tissue impairs glucose transport capacity, which manifests as elevated postprandial blood glucose levels in individuals with diabetes [30, 31].”
Epigenomic influence of the physical activity/inactivity in the origin of type 2 diabetes.
Andrade, J. L. M., & Navarrete, L. A. S. (2009) · RICYDE Revista Internacional de Ciencias del Deporte · Cited by 2
Changing horizons: approaches to diabetes care, current and future
Goldfine, A. B. (2007) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328095194f · Cited by 1
DNA Methylation in Metabolic Diseases
Neidhart, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420194-1.00011-7 · Cited by 1
Energy Metabolism in Skeletal Muscle and its Link to Insulin Resistance
Wang, M. (2011) · Wiley eBooks · doi:10.1002/9780470910016.ch6 · Cited by 1
The Skeletal Muscle in Metabolic Syndrome
Zorzano, A., Sebastián, D., & Romero, M. (2013) · Springer eBooks · doi:10.1007/978-3-319-01008-3_6 · Cited by 1
Paola, R. D., Tassi, V., & Trischitta, V. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01537.x · Cited by 1
Candidate genes for obesity and related phenotypes
Swarbrick, M. M. (2002) · UWA Profiles and Research Repository (UWA) · Cited by 1
Böttcher, Y., Kovacs, P. L., Tönjes, A., & Stümvoll, M. (2005) · Der Internist · doi:10.1007/s00108-005-1434-5 · Cited by 4
Fatty Acid and Glucose Metabolism in Cardiac Disease
Marín-García, J. (2007) · Elsevier eBooks · doi:10.1016/b978-012373698-7/50016-4 · Cited by 1
Identification and Biochemical Characterization of PGC-1beta-Interacting Proteins
Zhang, H. (2008) · KU ScholarWorks (The University of Kansas) · Cited by 1
Gene x lifestyle interactions in type 2 diabetes mellitus and related traits
Brito, E. C. (2010) · DiVA at Umeå University (Umeå University)
Pihlajamäki, J., & Patti, M. (2006) · Advances in molecular and cellular endocrinology · doi:10.1016/s1569-2566(06)05012-5 · Cited by 2
Signaling in Diabetes and Metabolic Syndrome
Marín-García, J. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9461-5_16
Cho, A., Jiang, Mann, Kawamoto, Robinson, Wang, McCarthy, Woodward, M., & Ginsburg (2012) · Comparative Effectiveness Research · doi:10.2147/cer.s26220
A REVIEW OF NUCLEAR RECEPTOR GENE ACTIVATION THROUGH COFACTOR PROTEIN INTERACTIONS
Baker, R. L. (2008) · KU ScholarWorks (The University of Kansas)
Enhanced methylglyoxal formation in cystathionine γ-lyase knockout mice
Untereiner, A. A. (2011) · University Library - University of Saskatchewan (University of Saskatchewan)
Estudio del factor de transcripción SREBP1 en estados de resistencia a insulina.
Vernia, S. (2007) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · Cited by 1
Alterata attività mitocondriale nella prole insulino-resistente di pazienti con diabete di tipo 2
Petersen, K. F., Dufour, S., Befroy, D. E., Garcia, R., Shulman, G. I., & PEZZINO, V. (2003) · L Endocrinologo · doi:10.1007/bf03344480
Metabolic Syndrome, Diabetes and Cardiometabolic Risks in Aging
Marín-García, J., Goldenthal, M. J., & Moe, G. W. P. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74072-0_9
Ann, E., Kang, H., 하창덕, 최규환, & 조진경 (2012) · Exercise Science · doi:10.15857/ksep.2012.21.4.417
Exenatide as a novel treatment for Parkinson's Disease
Avilés-Olmos, I. (2013) · UCL Discovery (University College London)
Nutrigenomic Implications for Nuclear Receptor Coactivators
Lonard, D. M., & O’Malley, B. W. (2011) · CRC Press eBooks · doi:10.1201/b11294-10
Hussey, R. C. (2013) · Arrow@dit (Dublin Institute of Technology)
Association of Polymorphisms in PPARPGC1A, ACE, and DRD2 Genes with Gestational Diabetes Mellitus
Оразмурадов, А. А., Викторовна, Б. И., Альбертовна, А. Г., Abitova, M. Z., Haddad, K., Lopatin, A., Kyrtikov, S. I., Eldashova, G., Mukovnikova, E. V., & Lukaev, A. (2021) · International Journal of Biomedicine · doi:10.21103/article11(1)_oa8
Excessive Nutrients and Regional Energy Metabolism
Perseghin, G. (2012) · Springer eBooks · doi:10.1007/978-88-470-2418-2_7
(2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.245
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-12125-3_27-2 · Cited by 1
Pancreatic Islet Adaptation and Failure in Obesity and Diabetes
Doliba, N. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_27
Excessive Nutrients and Regional Energy Metabolism
Perseghin, G. (2023) · Springer eBooks · doi:10.1007/978-3-031-27192-2_6
Mao, Y., Zhang, Z., Shen, Y., Li, M., Fei, X., Wang, D., Zhu, Q., Chen, X., & Du, J. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1652265
Contrôle de la masse fonctionnelle des cellules β pancréatiques par les glucocorticoïdes et pgc-1α
Besseiche, A. (2015) · theses.fr (ABES) · doi:10.70675/f16ecd6fza687z4a5fzac34zc26774dc9c3f
Carper, D. A. (2020) · theses.fr (ABES) · doi:10.70675/75973fe1z43fbz422cz9d70zf7b3b5b7e15f
Galipeau, M., Jouvet, N., Schoumacher, M., Courty, É., Vandenbeek, R., Güneş, A., Braud, M., Fourgeux, C., Poschmann, J., Lynn, F. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.16.759626
Regulation of Mitochondrial Fuel Handling by the Peroxisome Proliferator-Activated Receptors
Sugden, M. C., & Holness, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69945-5_3
Metadata
- Authors
- Ek, J., Andersen, G., Urhammer, S. A., Gæde, P. H., Drivsholm, T., Borch-Johnsen, K., Hansen, T., & Pedersen, O.
- Affiliations
- Glostrup Hospital (DK)
- Venue
- Diabetologia
- Published
- 2001-12-01
- Volume
- 44
- Issue
- 12
- Pages
- 2220-2226
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1984668213
- Cited by
- 293
- References
- 19
- Citations by year
- 2026: 2 · 2025: 4 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 8 · 2016: 3 · 2015: 11 · 2014: 7 · 2013: 12 · 2012: 15
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Funders
- Velux Stiftung
- Hjerteforeningen
- Sundhed og Sygdom, Det Frie Forskningsråd
- Diabetesforeningen
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PGC-1, type 2 diabetes, Gly482Ser polymorphism, genetic association, genotype relative risk, amino acid polymorphism, genetic susceptibility to diabetes
- MeSH terms
- Aged, Alleles, Amino Acid Sequence, Diabetes Mellitus, Type 2, DNA Mutational Analysis, Female, Gene Frequency, Genotype, Humans, Male, Middle Aged, Polymorphism, Genetic, Transcription Factors, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.